Prostate brachytherapy is widely used to treat patients with low-risk prostate cancer, but its use in patients at high risk of extracapsular cancer extension (ECE) is controversial. Dattoli and colleagues investigated the long-term biochemical control rates when external beam radiotherapy (EBRT) and...
PO-1048: HDR brachytherapy combined to EBRT for prostate cancer: analysis of toxicities and PSA bounce of a phase II trialPurpose To determine the demographic, clinical, decision-making, and quality-of-life factors that are associated ... A Tétreault-Laflamme,TV Nguyen,F Vincent,... - 《Ra...
"Many variations and intensifications of both EBRT and brachytherapy have been tested mainly in the higher and lower risk tiers of prostatecancerpatients. Intermediate-risk prostate cancer patients represent a vast and heterogeneous grouping, which can make it difficult to find a specific therapy combi...
EBRT or brachytherapy c Other local treatments for prostate d Active surveillance e Watchful waiting: for asymptomatic patients with expected survival < 10 years (based on complications) Adjuvant Therapy EBRT (no lymph node metastasis after radical surgery, but with adverse prognostic pathological ...
Finally, the advantage of using the combination brachytherapy plus EBRT over the latter alone has not been demonstrated (Preisser et al., 2020), remaining a controversial topic. It should also be considered that the use of the combination may cause increased rectal complications overall (Peschel ...
In general, for patients with low or intermediate risk, early stage prostate cancer, treatment with radical prostatectomy, EBRT or brachytherapy appears to produce equivalent outcomes but these treatments are associated with different side effects. In patients with higher risk disease, however, treatment...
Conventional treatment options for clinically localized, low-risk prostate cancer include radical prostatectomy, external-beam radiotherapy (EBRT) and low-dose-rate brachytherapy. Advances in image-guided radiotherapy (IGRT) since the 1980s, the development of intensity-modulated radiotherapy (IMRT) during...
Two types of radiation therapy are used in prostate cancer -- external beam radiation therapy and brachytherapy. Both are used to treat prostate cancer that has not spread outside the prostate. In terms of survival, radiotherapy appears to achieve similar results as those obtained with radical pro...
This study examined treatment effects in more comparable groups. Methods: From 2008–2011, 240 patients with localised prostate cancer were selected to be eligible for both radical prostatectomy (RP) and external beam radiotherapy (EBRT). Brachytherapy (BT) was a third option for some. Health-...
cancer, including external-beam radiotherapy (EBRT), brachytherapy, radical prostatectomy; or conservative management strategies for favourable-risk prostate cancer to delay or avoid aggressive treatment and potential side effects [9]. Potential treatment-related toxicities and side effects often affect ...